1. Home
  2. PDFS vs HTFL Comparison

PDFS vs HTFL Comparison

Compare PDFS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$55.92

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

HTFL

Heartflow Inc.

HOLD

Current Price

$26.78

Market Cap

2.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
HTFL
Founded
1992
2007
Country
United States
United States
Employees
N/A
843
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.5B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
PDFS
HTFL
Price
$55.92
$26.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$39.67
$38.20
AVG Volume (30 Days)
812.0K
2.1M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.12
N/A
Revenue
N/A
N/A
Revenue This Year
$22.13
$27.66
Revenue Next Year
$18.92
$23.55
P/E Ratio
$466.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.19
$20.13
52 Week High
$71.69
$41.22

Technical Indicators

Market Signals
Indicator
PDFS
HTFL
Relative Strength Index (RSI) 46.99 39.35
Support Level $27.68 $24.77
Resistance Level $56.46 $32.69
Average True Range (ATR) 4.21 2.33
MACD -1.80 -0.82
Stochastic Oscillator 26.83 8.73

Price Performance

Historical Comparison
PDFS
HTFL

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About HTFL Heartflow Inc.

HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.

Share on Social Networks: